Literature DB >> 15931381

Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume.

Fitz-Roy E Curry1.   

Abstract

Atrial natriuretic peptide (ANP) acts acutely to reduce plasma volume by at least 3 mechanisms: increased renal excretion of salt and water, vasodilation, and increased vascular permeability. Authors of a study in this issue of the JCI performed a knockout of the receptor for ANP in vascular endothelia in order to distinguish the effects of ANP-dependent increases in vascular permeability from those of other endocrine actions of ANP in the regulation of plasma volume. The knockout mice exhibited reduced vascular permeability to plasma protein, resulting in chronically increased plasma volume, arterial hypertension, and cardiac hypertrophy. Renal excretion and vasodilation did not account for these changes. Thus ANP-induced increases in endothelial permeability may be critical to the ability of ANP to lower arterial blood pressure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15931381      PMCID: PMC1137012          DOI: 10.1172/JCI25417

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  7 in total

Review 1.  Microvascular permeability.

Authors:  C C Michel; F E Curry
Journal:  Physiol Rev       Date:  1999-07       Impact factor: 37.312

2.  Oncotic pressures opposing filtration across non-fenestrated rat microvessels.

Authors:  R H Adamson; J F Lenz; X Zhang; G N Adamson; S Weinbaum; F E Curry
Journal:  J Physiol       Date:  2004-04-08       Impact factor: 5.182

Review 3.  The natriuretic peptides.

Authors:  Gary F Baxter
Journal:  Basic Res Cardiol       Date:  2004-01-23       Impact factor: 17.165

4.  Plasma ANP levels and protein extravasation during graded expansion with equilibrated whole blood.

Authors:  V L Tucker
Journal:  Am J Physiol       Date:  1996-09

Review 5.  Diverse biological actions of atrial natriuretic peptide.

Authors:  B M Brenner; B J Ballermann; M E Gunning; M L Zeidel
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

6.  Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide.

Authors:  Karim Sabrane; Markus N Kruse; Larissa Fabritz; Bernd Zetsche; Danuta Mitko; Boris V Skryabin; Melanie Zwiener; Hideo A Baba; Masashi Yanagisawa; Michaela Kuhn
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

7.  Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure.

Authors:  Rita Holtwick; Michael Gotthardt; Boris Skryabin; Martin Steinmetz; Regine Potthast; Bernd Zetsche; Robert E Hammer; Joachim Herz; Michaela Kuhn
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

  7 in total
  29 in total

1.  Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.

Authors:  Junjie Xing; Bakhtiyor Yakubov; Valeriy Poroyko; Anna A Birukova
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

Review 2.  Physiology of natriuretic peptides: The volume overload hypothesis revisited.

Authors:  Olli Arjamaa
Journal:  World J Cardiol       Date:  2014-01-26

Review 3.  Associations among NPPA gene polymorphisms, serum ANP levels, and hypertension in the Chinese Han population.

Authors:  Huan Zhang; Xingbo Mo; Zhengyuan Zhou; Zhengbao Zhu; Xinfeng HuangFu; Tan Xu; Aili Wang; Zhirong Guo; Yonghong Zhang
Journal:  J Hum Hypertens       Date:  2019-07-24       Impact factor: 3.012

Review 4.  Hypertension.

Authors:  Suzanne Oparil; Maria Czarina Acelajado; George L Bakris; Dan R Berlowitz; Renata Cífková; Anna F Dominiczak; Guido Grassi; Jens Jordan; Neil R Poulter; Anthony Rodgers; Paul K Whelton
Journal:  Nat Rev Dis Primers       Date:  2018-03-22       Impact factor: 52.329

5.  Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study.

Authors:  Valentina Cannone; Brenda K Huntley; Timothy M Olson; Denise M Heublein; Christopher G Scott; Kent R Bailey; Margaret M Redfield; Richard J Rodeheffer; John C Burnett
Journal:  Hypertension       Date:  2013-09-16       Impact factor: 10.190

6.  The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion.

Authors:  Barbara Schreier; Sebastian Börner; Katharina Völker; Stepan Gambaryan; Stephan C Schäfer; Peter Kuhlencordt; Birgit Gassner; Michaela Kuhn
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

Review 7.  Exploring the potential ergogenic effects of glycerol hyperhydration.

Authors:  Jeff L Nelson; Robert A Robergs
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

8.  Atrial natriuretic peptide modulation of albumin clearance and contrast agent permeability in mouse skeletal muscle and skin: role in regulation of plasma volume.

Authors:  Fitz-Roy E Curry; Cecilie Brekke Rygh; Tine Karlsen; Helge Wiig; Roger H Adamson; Joyce F Clark; Yueh-Chen Lin; Birgit Gassner; Frits Thorsen; Ingrid Moen; Olav Tenstad; Michaela Kuhn; Rolf K Reed
Journal:  J Physiol       Date:  2009-11-30       Impact factor: 5.182

9.  Blood Pressure Genetic Risk Score Predicts Blood Pressure Responses to Dietary Sodium and Potassium: The GenSalt Study (Genetic Epidemiology Network of Salt Sensitivity).

Authors:  Jovia L Nierenberg; Changwei Li; Jiang He; Dongfeng Gu; Jichun Chen; Xiangfeng Lu; Jianxin Li; Xigui Wu; C Charles Gu; James E Hixson; Dabeeru C Rao; Tanika N Kelly
Journal:  Hypertension       Date:  2017-10-09       Impact factor: 10.190

10.  A mathematical model of brain glucose homeostasis.

Authors:  Lu Gaohua; Hidenori Kimura
Journal:  Theor Biol Med Model       Date:  2009-11-27       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.